CivicaScript, LLC – Trademark Portfolio

Entity Type: 16

CivicaScript, LLC holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 8 are pending. Notable registered marks include MAXRP and ABIRTEGA. The owner is based in Lehi, UT.

2912 Executive Parkway, Suite 320

Lehi, UT 84043

13 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CivicaScript, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (12 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does CivicaScript, LLC have?

CivicaScript, LLC has 13 U.S. trademarks filed with the USPTO. Of these, 2 registered, 8 pending, 3 abandoned.

What trademark classes does CivicaScript, LLC file in?

CivicaScript, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are CivicaScript, LLC's most well-known trademarks?

CivicaScript, LLC's registered trademark portfolio includes well-known marks such as MAXRP and ABIRTEGA. These are among 2 currently registered trademarks in the portfolio.

What is CivicaScript, LLC's trademark registration success rate?

CivicaScript, LLC has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 8 applications are pending review.